FDA Clears First Blood Test for Diagnosing Alzheimer’s Disease
In a significant medical breakthrough, the U.S. Food and Drug Administration (FDA) has cleared the first blood-based in vitro diagnostic test to aid in diagnosing Alzheimer’s disease on May 16, 2025. The Lumipulse G pTau217/ß-Amyloid 1-42…